HealthEquity (HQY) Announces 2.5M Share Common Stock Secondary Offering

October 19, 2016 4:12 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

HealthEquity, Inc. (Nasdaq: HQY) announced the commencement of an underwritten secondary offering of shares of its common stock. Certain of HealthEquity’s stockholders are offering 2,500,000 shares of the company’s common stock for sale. Additionally, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 375,000 shares of the company’s common stock. HealthEquity will not receive any proceeds from the sale of the shares offered by the selling stockholders.

Jefferies LLC and Raymond James & Associates, Inc. are acting as joint book-running managers for the offering.

The shares are being offered pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (SEC). The offering is being made only by means of a prospectus supplement and accompanying prospectus. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Copies of the preliminary prospectus supplement and accompanying prospectus relating to the offering, when available, may be obtained from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 547-6340, or by email at prospectus_department@jefferies.com; or from Raymond James & Associates, Inc., Attention: Prospectus Department, 880 Carillon Parkway, St. Petersburg, FL 33716, or by telephone at (800) 248-8863, or by email at prospectus@raymondjames.com.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Related Entities

Raymond James, Jefferies & Co, Putnam Investments

Add Your Comment